Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
9 randomized controlled trials involving 1,760 patients with advanced radioiodine-refractory differentiated thyroid cancer were analyzed. The dataset contains results from a Bayesian network meta-analysis comparing the efficacy and safety of targeted therapies, including lenvatinib, anlotinib, apatinib, and cabozantinib. It was authored by Pin Wang and uploaded to figshare on 2026-03-18.
Data is in XLS format. License is CC-BY-4.0, requiring attribution.